Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Quantifying the effects of renal impairment on plasma concentrations of the neuroendocrine neoplasia biomarkers chromogranin A, chromogranin B, and cocaine- and amphetamine-regulated transcript.

× No keyword cloud information.

13 in total

Review 1. Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan.

Authors: Tetsuhide Ito; Susumu Hijioka; Toshihiko Masui; Atsuko Kasajima; Yuji Nakamoto; Noritoshi Kobayashi; Izumi Komoto; Masayuki Hijioka; Lingaku Lee; Hisato Igarashi; Robert Thomas Jensen; Masayuki Imamura
Journal: J Gastroenterol Date: 2016-08-18 Impact factor: 7.527

2. Somatostatin receptors over-expression in castration resistant prostate cancer detected by PET/CT: preliminary report of in six patients.

Authors: Giordano Savelli; Alfredo Muni; Roberta Falchi; Alberto Zaniboni; Roberto Barbieri; Giuseppe Valmadre; Chiara Minari; Camilla Casi; Pierluigi Rossini
Journal: Ann Transl Med Date: 2015-06

3. A score derived from routine biochemical parameters increases the diagnostic accuracy of chromogranin A in detecting patients with neuroendocrine neoplasms.

Authors: Ivan Kruljac; Ivan Vurnek; Sebastian Maasberg; Davor Kust; Kristina Blaslov; Blaženka Ladika Davidović; Mario Štefanović; Alma Demirović; Alen Bišćanin; Jakša Filipović-Čugura; Jasmina Marić Brozić; Ulrich-Frank Pape; Milan Vrkljan
Journal: Endocrine Date: 2018-04-09 Impact factor: 3.633

4. Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors.

Authors: Masami Miki; Tetsuhide Ito; Masayuki Hijioka; Lingaku Lee; Kohei Yasunaga; Keijiro Ueda; Takashi Fujiyama; Yuichi Tachibana; Ken Kawabe; Robert T Jensen; Yoshihiro Ogawa
Journal: Jpn J Clin Oncol Date: 2017-06-01 Impact factor: 3.019

5. Neuroendocrine Differentiation of Prostate Cancer Metastases Evidenced "in Vivo" by ⁶⁸Ga-DOTANOC PET/CT: Two Cases.

Authors: Giordano Savelli; Alfredo Muni; Roberto Barbieri; Giuseppe Valmadre; Giorgio Biasiotto; Chiara Minari; Claudio Ghimenton; Renato Pagani; Elisa Pecini; Matteo Falcone
Journal: World J Oncol Date: 2014-05-06

6. Peptide receptor radionuclide therapy with (90)Y-DOTATATE/(90)Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity.

Authors: S Vinjamuri; T M Gilbert; M Banks; G McKane; P Maltby; G Poston; H Weissman; D H Palmer; J Vora; D M Pritchard; D J Cuthbertson
Journal: Br J Cancer Date: 2013-03-14 Impact factor: 7.640

10. Reference limits for chromogranin A, CYFRA 21-1, CA 125, CA 19-9 and carcinoembryonic antigen in patients with chronic kidney disease.

Authors: Gustav Mikkelsen; Arne Åsberg; Maria E Hultström; Knut Aasarød; Gunhild G Hov
Journal: Int J Biol Markers Date: 2017-10-31 Impact factor: 2.659

Quantifying the effects of renal impairment on plasma concentrations of the neuroendocrine neoplasia biomarkers chromogranin A, chromogranin B, and cocaine- and amphetamine-regulated transcript.